AIxCrypto Integrates Regulated Payments via BitMart Co-Branded Virtual Card, Expands Web3 Hub
- AIxCrypto is embedding its Web3 ecosystem into regulated payment rails to convert digital assets into real-world, compliance-aware payments.
- AIxCrypto partners with BitMart on a co-branded virtual prepaid card, acting as gateway while BitMart handles issuance and compliance.
- AIxCrypto reports 1.64M registered wallets, Season 2 upgrades, and AI-driven Web2-to-Web3 gateway features for broader user onboarding.
AIxCrypto moves payments closer to everyday use
AIxCrypto Inc. reports a strategic push to embed its Web3 ecosystem into regulated payment rails, signaling a move from experimental crypto utility toward mainstream payments and compliance-aware partnerships. The company says the step is aimed at converting community activity and digital assets into real-world user experiences while keeping regulated financial operations with licensed operators.
Co-branded virtual card deal positions AIxCrypto as gateway, not bank
AIxCrypto announces a partnership with BitMart to launch a co-branded virtual prepaid card program that targets eligible users across the AIxC ecosystem. Co-CEO Jerry Wang says AIxCrypto supplies community reach, brand participation and marketing support, while BitMart acts as the exclusive operator handling card issuance, user onboarding, compliance oversight, customer support and payment infrastructure subject to applicable regulatory and regional requirements.
The arrangement underscores AIxCrypto’s intent to separate product and community development from regulated financial functions, keeping operational control of payments with a licensed partner. Company messaging frames the deal as a way to provide “real-world utility” for token holders and ecosystem participants without exposing AIxCrypto to the licensing, compliance and consumer-facing obligations tied to issuing payments products.
Executives stress that the program forms part of a broader roadmap emphasizing scalable, compliant payment rails and AI-driven automation. Management positions the card as an integration point to bring users from Web2-style experiences into Web3 services, while minimizing legal and operational risk through clear contractual and functional boundaries.
Gaming season closed, platform upgrades roll out
AIxCrypto also concludes S1 Arena, the inaugural competitive season on AIxC Hub, and launches Season 2 as a platform upgrade. The company reports more than 1.64 million registered wallet addresses and over 7,200 registered teams, and says Season 2 transforms the Hub into a Web2-to-Web3 gateway powered by AI Agent infrastructure and integrated with its EAI‑RWA ecosystem, adding features like Tenki Stargaze and Fortune Collection.
Conference engagement drives institutional follow-ups
On the events front, AIxCrypto co-hosts a ConsensusHK 2026 panel titled “Beyond Scaling: AIxC and the Era of Autonomous DeFi,” and the company says it is turning conference momentum into institutional conversations. Management indicates the near-term roadmap prioritizes developer tooling, institutional outreach and converting partnerships and integrations into measurable user onboarding over coming quarters.
Related Cashu News

CRISPR Therapeutics AG Achieves Financial Progress Amid Advancements in Gene-Editing Portfolio
CRISPR Therapeutics AG (Ticker: UNDEFINED) showcases a pivotal moment in its financial journey with the release of its results for the first quarter of 2026. Highlighting a revenue of $1.46 million, t…

MetaVia to Present Innovative Cardiometabolic Research at 2026 ADA Scientific Sessions
MetaVia is set to showcase its innovative research in cardiometabolic diseases at the upcoming American Diabetes Association (ADA) Scientific Sessions in 2026, following the acceptance of three late-b…

Ionis Pharmaceuticals Advances TRYNGOLZA for Hypertriglyceridemia and Diranersen for Alzheimer's Disease
Ionis Pharmaceuticals has made headlines in the biotechnology sector with the promising potential of its drug TRYNGOLZA, which is designed to treat severe hypertriglyceridemia. During a recent healthc…

ImmunityBio Partners with BCG Laboratory to Enhance Bladder Cancer Treatment Supply and Options
ImmunityBio has secured a critical partnership with Japan's BCG Laboratory to enhance the supply of Bacillus Calmette-Guérin (BCG) in the United States, addressing an urgent need in the treatment of b…